ロード中...
Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513
Dengue is a widespread viral disease with 3.6 billion people at risk worldwide. Humanized monoclonal antibody (mAb) 513, currently undergoing clinical trials in Singapore, targets an epitope on the envelope protein domain III exposed at the surface of the viral particle. This antibody potently neutr...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5981469/ https://ncbi.nlm.nih.gov/pubmed/29855525 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-26800-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|